RxDoctor Payments Data

Brittany Harlow, DO

Family Medicine · Hazard, KYNPI 1518349190

Payments from drug & device makers

$393in general payments, 2019–2025

Across 22 payments — averaging $17.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$138
  • Lilly USA, LLC$115
  • Boehringer Ingelheim$57
  • Acadia Pharmaceuticals Inc$23
  • Tactile Systems Technology Inc$21
  • Amgen$14
  • plus $26 from 2 others

What the payments were for

  • Food & beverage$393100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$393 in reported general payments places this provider in the 40th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$9,191
Medicare patients
43
Services billed
114

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide96$95,762
FarxigaDapagliflozin Propanediol104$68,378
OzempicSemaglutide54$51,013
TrulicityDulaglutide49$43,015
XifaxanRifaximin12$40,200
EliquisApixaban54$35,479
JardianceEmpagliflozin22$19,968
LinzessLinaclotide31$19,796
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$18,392
JanuviaSitagliptin Phosphate19$10,581
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog29$8,939
XareltoRivaroxaban12$8,596
VascepaIcosapent Ethyl24$8,029
Spiriva HandihalerTiotropium Bromide12$7,079
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr14$6,374

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$115$138,777145 claims
AstraZenecaFarxiga$14$68,378104 claims
PfizerEliquis$138$35,47954 claims
Boehringer IngelheimJardiance$57$19,96822 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Hazard

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →